EIF4A1 and metastatic neoplasm: Accordingly, elevated expression of RPs and Eif4a1 was also detected in both prostate primary and metastatic tumor cells, aligning with upregulated XPO1, HGF/MET, and Wnt/β-catenin downstream target expression.